Approval · Notice of Compliance 11368 · 2010
MYOZYME: Notice of Compliance 11368
Issued May 12, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 11368
- Date
- May 12, 2010
- Company
- Genzyme Canada Inc
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Manufacturing scale-up at a new manufacturing facility
- Therapeutic class
- Enzyme replacement therapy
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MYOZYME | Not yet assigned | — |
Medicinal ingredients
- ALGLUCOSIDASE ALFA 50 MG per VIAL